Hypothesis: The metastatic niche theory can elucidate infantile hemangioma development

Journal of Cutaneous Pathology

Volumn 37, Issue SUPPL. 1, 2010, Pages 83-87

  Mihm Jr , Martin C ^a   Nelson, J Stuart ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEMANGIOMA; HUMAN; INFANT; METASTASIS; PATHOLOGY; PATHOPHYSIOLOGY; SKIN TUMOR;

HEMANGIOMA; HUMANS; INFANT; NEOPLASM METASTASIS; SKIN NEOPLASMS;

EID: 77949952457     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2010.01521.x     Document Type: Article

References (23)

1. North PE, Mizeracki A, Waner M, Mihm MC Jr. GLUT1: a newly discovered marker for juvenile hemangiomas. Human Pathol 2000 31 (1 11.
2. North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001 137 (5 559.
3. Barnés CM, Huang S, Kaipainen A, et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci U S A 2005 102 (52 19097.
4. Paget S. The distribution of secondary growths in cancer of the breast 1889. Cancer Metastasis Rev 1989 8 : 98.
5. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nature Publishing Group. Vol. 2, 2002.
6. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nature Publishing Group, Vol. 8, 2007.
7. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005 438 (7069 820.
8. Kaplan RN, Rafii S, Lyden D. Preparing the "Soil": the premetastatic niche. Cancer Res 2006 66 (23 2006.
9. Gupta GP, Massague J. Cancer Metastasis: Building a Framework. Cell 2006 127, 679. Elsevier Inc.
10. Li F, Tiede B, Massagué J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 2007 17 (1 3.
11. Psaila B, Lyden D. The metastatic niche: Adapting the foreign soil. Nature Reviews/Cancer 2009 9, 285.
12. Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm MC Jr. The nonrandom distribution of facial hemangiomas. Arch Dermatol 2003 139 (7 869.
13. Ritter MR, Butschek RA, Friedlander M, Friedlander SF. Pathogenesis of infantile hemangioma: new molecular and cellular insights. Expert Rev Mol Med 2007 9 (32 1. Review.
14. Bakaris S, Karabiber H, Yuksel M, Parmaksiz G, Kiran H. Case of large placental chorioangioma associated with diffuse neonatal hemangiomatosis. Pediatr Dev Pathol 2004 7 (3 258.
15. Metry, DW, Hebert AA. Benign cutaneous vascular tumors of infancy: when to worry, what to do. Arch Dermatol 2000 136 (7 905.
16. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood 2000 95 (3 952.
17. Yu Y, Fuhr J, Boye E, et al. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells 2006 24 (6 1605.
18. Ritter MR, Reinisch J, Friedlander SF, Friedlander M. Myeloid cells in infantile hemangioma. Am J Pathol 2006 168 (2 621.
19. Lo K, Mihm MC, Fay A. Current theories on the pathogenesis of infantile hemangioma. Semin Ophthalmol 2009 24 (3 172.
20. Bischoff J. Progenitor cells in infantile hemangioma. J Craniofac Surg 2009 1 (Suppl): 695. Review. Erratum in: J Craniofac Surg 2009; 20 (5 1629.
21. Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma. Angiogenesis 2009 12 (2 197.
22. Jinnin M, Medici D, Park L, et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 2008 14 (11 1236.
23. Phung TL, Oble DA, Jia W, Benjamin LE, Mihm MC Jr. Nelson JS. Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks. Lasers Surg Med 2008 40 (1 1.